Vireo Growth (VREOF) Change in Intangibles (2022)
Vireo Growth (VREOF) posted Change in Intangibles of $236635.0 for Q1 2022.
Vireo Growth (VREOF) Change in Intangibles (2022) Analysis & Trends
Vireo Growth has reported Change in Intangibles for 1 years, with the latest figure at $236635.0 in Q1 2022.
- Quarterly Change in Intangibles changed N/A year-over-year to $236635.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $236635.0 (changed N/A YoY) and the FY2022 annual result came in at $236635.0, changed N/A from the prior year.
- Change in Intangibles steadied at $236635.0 in Q1 2022 per VREOF's latest filing.
- Over five years, Change in Intangibles peaked at $236635.0 in Q1 2022 and troughed at $236635.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -310.09 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Vireo Growth | 489.19 Mn | 346.89 Mn | 95.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 236,635.00 |
| Mar 31, 2022 | 236,635.00 |